Doctors shunning pharma rep visits
May 11, 2010pharma, sales force, sales force effectiveness, sales representatives
More and more doctors in the US are refusing to see pharma companies’ sales representatives, according to new research. The …
Bayer colon cancer drug moves into phase III
May 11, 2010Research and Development Bayer, colorectal cancer, regorafenib
Bayer Schering Pharma will shortly begin phase III tests of its investigational compound regorafenib for patients with metastatic colorectal cancer. …
Merck gains rights to cancer treatment
May 10, 2010Research and Development Ariad Pharmaceuticals, Merck & Co, NSCLC
Merck has acquired an exclusive license for a new cancer drug that’s in trials for a number of different forms …
Anti-counterfeiting pilot a success, says EFPIA
May 10, 2010Sales and Marketing counterfeits, supply chain
A pilot project aimed at stopping counterfeit medicines getting into the supply chain has been a resounding success, according to …
Teva reports strong Q1 results
May 10, 2010Sales and Marketing 2010 financials, Teva
Generics firm Teva Pharmaceuticals has reported strong first quarter results, driven by its patented multiple sclerosis therapy Copaxone. Sales of …
Professor Sander van Deventer appointed to AMT supervisory board
May 10, 2010Research and Development AMT, Amsterdam Molecular Therapeutics, appointment, research and development
Dutch human gene therapy company Amsterdam Molecular Therapeutics has appointed Professor Sander van Deventer to its supervisory board. One of …
Pharma manufacturing news in brief
May 10, 2010Manufacturing and Production American Peptide, DSM Biologics, Dutch CMO SynCo Bio Partners, KV Pharmaceutical, Merck & Co, manufacturing
This week’s round-up of pharmaceutical manufacturing news includes facility updates from KV Pharmaceutical, DSM Biologics, Merck & Co and American …
In search of a real solution to the counterfeit problem
May 10, 2010Manufacturing and Production Plavix, counterfeits, supply chain
For a great deal of the last decade, warnings from the pharmaceutical industry about the growing threat of counterfeit medicines …
Boehringer signs antibody myeloma R&D deal
May 10, 2010Research and Development Boehringer, Cancer, Micromet, myeloma
Boehringer Ingelheim and US biotech company Micromet are to research and develop a new BiTE antibody to treat multiple myeloma. …
Lundbeck delivers strong results and builds on pipeline
May 7, 20102010 financials, Azilect, Lundbeck
Denmark-based Lundbeck has seen a large jump in revenue for the first quarter thanks to steady growth from its lead …
European court backs prescribing incentives
May 7, 2010Sales and Marketing prescribing incentives
Payments to persuade UK doctors to prescribe generics have been backed by a European court, thwarting pharma attempts to have …
Digital Pharma: Novartis rebuked for “false and misleading” websites
May 7, 2010Medical Communications disease awareness campaigns
The FDA has issued Novartis with a stern warning over two websites it sponsors, saying it considers gistalliance.com and cmlalliance.com …
Mixed fortunes for major CROs in Q1
May 7, 2010Research and Development CRO, Covance, ICON, PPD, Parexel, contact research, contract research, contract research organisation
Leading contract research organisations (CROs) reported a mixed bag of financial results for the first three months of 2010, although …
Encouraging data for ThromboGenics and BioInvent product
May 7, 2010BioInvent, Lovenox, ThromboGenics, VTE
An antibody-based drug to prevent blood clots after orthopaedic surgery has shown promising results in phase II. TB-402 is a …
Congress to probe McNeil’s GMP violations
May 7, 2010Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance
The US Food and Drug Administration may take additional regulatory action against Johnson & Johnson subsidiary McNeil Consumer Healthcare over …
EMA appoints Alexis Nolte head of quality
May 7, 2010Manufacturing and Production EMA, appointment, manufacturing and production
The European Medicines Agency has appointed Alexis Nolte to head up its Quality of Medicines Sector. He was previously principal …
New audiences, new marketing tools
May 6, 2010Sales and Marketing brand, branding, marketing, marketing ideas
Pharmaceutical industry marketers have for many years focused on turning good products into great brands, developing strong core propositions which …
Congress criticises FDA over contaminated heparin case
May 6, 2010Manufacturing and Production heparin, manufacturing compliance
The US Food and Drug Administration’s follow-up of the contaminated heparin scandal which surfaced in 2008 has been inadequate, according …
AZ signs tuberculosis drug discovery deal
May 6, 2010Research and Development AstraZeneca, India, TB, tuberculosis
AstraZeneca and the Global Alliance for TB Drug Development are to collaborate on the discovery and development of drugs to treat tuberculosis.The two …
Abbott’s Mark Kontny joins Patheon
May 6, 2010Manufacturing and Production Patheon, appointment, manufacturing and production
Patheon has appointed Dr Mark Kontny president of global pharmaceutical development services and chief scientific officer. He joins the contract …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
